Saba Capital Management, L.P. filed a Form 4 on November 4, 2026, disclosing a purchase of 100 shares of Gabelli Healthcare & WellnessRx Trust common stock on November 3, 2026.

Key Highlights

  • Reporting person: Saba Capital Management, L.P., identified as a 10% owner of Gabelli Healthcare & WellnessRx Trust (NYSE:GRX).
  • Transaction: 100 shares of common stock acquired (transaction code P, indicating a purchase) on November 3, 2026.
  • Price paid: $10.18 per share, as reported in the filing.
  • Beneficial ownership following transaction: 2,186,122 shares held indirectly.
  • Indirect ownership: Shares are held by funds and/or accounts for which Saba Capital Management, L.P. serves as investment manager.
  • Key principal: Boaz R. Weinstein serves as managing member of Saba Capital Management GP, LLC, the general partner of Saba Capital Management, L.P.

Saba Capital Management's November 3 Purchase of GRX Common Stock

According to the Form 4 filed with the SEC on November 4, 2026, Saba Capital Management, L.P. reported the acquisition of 100 shares of Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) common stock at a price of $10.18 per share. The transaction date is listed as November 3, 2026, and the transaction code is recorded as "P," denoting an open-market purchase.

The filing states that the securities reported are held indirectly, specifically "by funds and/or accounts for which Saba Capital Management, L.P. serves as investment manager." Boaz R. Weinstein is identified as the managing member of Saba Capital Management GP, LLC, which serves as the general partner of Saba Capital Management, L.P. The filing was signed by Maria Piccolino on behalf of Saba Capital Management, L.P., and also carries Boaz Weinstein's signature, both dated November 4, 2026.

Following this reported transaction, the total amount of common stock beneficially owned by the reporting person is listed as 2,186,122 shares, held indirectly. The filing indicates Saba Capital Management, L.P. holds the status of a 10% owner relative to the issuer. No derivative securities transactions were reported in Table II of the filing.

What Was Disclosed

Saba Capital Management, L.P. disclosed a purchase of 100 shares of GRX common stock at $10.18 per share on November 3, 2026, bringing its indirectly held beneficial ownership to 2,186,122 shares, according to the Form 4 filing.